Last reviewed · How we verify
NCT05733338
The Effects of Intermittent Hypoxia on Acute Hypoxic Injury
NA trial testing Intermittent Hypoxia in Acute Mountain Sickness in 100 participants. Status unknown.
30 April 2023
Quick facts
| Lead sponsor | Capital Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 100 |
| Start date | 1 March 2023 |
| Primary completion | 30 April 2023 |
| Estimated completion | 30 April 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Intermittent Hypoxia
- Sham Intermittent Hypoxia
Conditions studied
- Acute Mountain Sickness — all drugs for Acute Mountain Sickness →
Sponsor
Capital Medical University
Who can join
Adults 18 to 45, any sex, with Acute Mountain Sickness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study intends to further reveal the effectiveness of intermittent hypoxia in preventing acute hypoxic injury.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Intermittent hypoxia training improves cerebral blood flow without cognitive impairment.
Zhang Q, Wang Q, Jin F, Huang D, et al · · 2025 · cited 6× · PMID 39543930 · DOI 10.1002/acn3.52248 -
Intermittent hypoxia preconditioning can attenuate acute hypoxic injury after a sustained normobaric hypoxic exposure: A randomized clinical trial.
Wang Y, Zhang Q, Ma Q, Wang Q, et al · · 2024 · cited 5× · PMID 38477221 · DOI 10.1111/cns.14662 -
Enhancing of cerebral Abeta clearance by modulation of ABC transporter expression: a review of experimental approaches.
Loeffler DA. · · 2024 · cited 2× · PMID 38872626 · DOI 10.3389/fnagi.2024.1368200
Verify or expand the search:
- PubMed search for NCT05733338
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intermittent Hypoxia
Trials testing the same drug.
- NCT07394699 — Efficiency of Intermittent Hypoxia Intervention in Primary Insomnia · NA · not yet recruiting
- NCT05824104 — Exploratory Study of Intermittent Hypoxia Treatment in Chronic Cerebral Hypoperfusion · NA · unknown
- NCT05463042 — Intermittent Hypoxia and Balance Control · NA · completed
- NCT04280484 — Acute Intermittent Hypoxia in Persons With Multiple Sclerosis · NA · completed
- NCT03029559 — Intermittent Hypoxia and Inspiratory Threshold Loading to Enhance Inspiratory Muscle Function · NA · completed
Other recruiting trials for Acute Mountain Sickness
Currently open trials in the same condition.
- NCT07126834 — Voluntary Isocapnic Hyperpnea in Hypoxia to Mitigate Acute Mountain Sickness · NA · active not recruiting
- NCT06499714 — HighCycle Study: Effect of High Altitude on Acute Mountain Sickness in Women Related to Their Menstrual Cycle Phase · recruiting
Other Capital Medical University trials
Trials by the same sponsor.
- NCT07379437 — Haematococcus Pluvialis Astaxanthin for Brain Aging · NA · not yet recruiting
- NCT07531394 — Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic St · Phase 3 · not yet recruiting
- NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
- NCT07513233 — Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL) · Phase 1 · not yet recruiting
- NCT07495358 — Development and Usability Evaluation of a Knowledge Graph-Based Symptom Management System for Patients With Breast Cance · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05733338 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Capital Medical University
- Last refreshed: 29 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05733338.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing